Commodore Capital LP 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 5:08 pm Sale | 2025-09-30 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Commodore Capital LP | 3,028,335 4.600% | -321,665 (-9.60%) | Filing |
| 2025-04-10 4:05 pm Purchase | 2025-04-03 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Commodore Capital LP | 3,350,000 5.000% | 3,350,000 (New Position) | Filing |